| Ticker | Current Price | % Daily Change | Volume (1,000s) | Average Volumn (1,000s) | Market Cap (Millions) | 1/2/2024 Price | % Change Since Inception 1/2/2024 |
|---|---|---|---|---|---|---|---|
| LPTX | $3.06 | -9.601% | 300 | 396 | $117 | $4.67 | -34.5% |
Leap Therapeutics, Inc.
47 Thorndike Street
Suite B1-1
Cambridge, MA 02141
United States
Leap Therapeutics (NASDAQ: LPTX) is a clinical-stage biopharmaceutical company acquiring and developing novel therapeutics at the leading edge of cancer research.